30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

por Leopold, Christine, Chambers, James D, Wagner, Anita K
Publicado 2015

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand

por Leopold, Christine, Lu, Christine Y., Wagner, Anita K.
Publicado 2020

Quality use of medicines within universal health coverage: challenges and opportunities

por Wagner, Anita K, Quick, Jonathan D, Ross-Degnan, Dennis
Publicado 2014

Medicines coverage and community-based health insurance in low-income countries

por Vialle-Valentin, Catherine E, Ross-Degnan, Dennis, Ntaganira, Joseph, Wagner, Anita K
Publicado 2008

Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces

por Chen, Wen, Tang, Shenglan, Sun, Jing, Ross-Degnan, Dennis, Wagner, Anita K
Publicado 2010

Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program

por Leopold, Christine, Araujo-Lane, Carina, Rosenberg, Carol, Gilkey, Melissa, Wagner, Anita K.
Publicado 2019

The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data

por Yang, Yu, Zhang, Yichen, Wagner, Anita K, Li, Huangqianyu, Shi, Luwen, Guan, Xiaodong
Publicado 2023

Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines

por Wagner, Anita K, Valera, Madeleine, Graves, Amy J, Laviña, Sheila, Ross-Degnan, Dennis
Publicado 2008

Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand

por Sruamsiri, Rosarin, Ross-Degnan, Dennis, Lu, Christine Y., Chaiyakunapruk, Nathorn, Wagner, Anita K.
Publicado 2015

Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil

por Ivama-Brummell, Adriana Mitsue, Wagner, Anita K, Pepe, Vera Lúcia Edais, Naci, Huseyin
Publicado 2022

Need for and Access to Health Care and Medicines: Are There Gender Inequities?

por Wagner, Anita K., Graves, Amy J., Fan, Zhengyu, Walker, Saul, Zhang, Fang, Ross-Degnan, Dennis
Publicado 2013

Health care payments in the asia pacific: validation of five survey measures of economic burden

por Reddy, Sheila R, Ross-Degnan, Dennis, Zaslavsky, Alan M, Soumerai, Stephen B, Wagner, Anita K
Publicado 2013

Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand

por Lu, Christine Y, Emmerick, Isabel Cristina M, Stephens, Peter, Ross-Degnan, Dennis, Wagner, Anita K
Publicado 2015

Article 3: 1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities

por Trap, Birna, Sembatya, Moses N., Imi, Monica, Seru, Morries, Wagner, Anita K., Ross-Degnan, Dennis
Publicado 2020

Patient access schemes in Asia-pacific markets: current experience and future potential

por Lu, Christine Y, Lupton, Caitlin, Rakowsky, Shana, Babar, Zaheer-Ud-Din, Ross-Degnan, Dennis, Wagner, Anita K
Publicado 2015

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis

por Sruamsiri, Rosarin, Wagner, Anita K, Ross-Degnan, Dennis, Lu, Christine Y, Dhippayom, Teerapon, Ngorsuraches, Surachat, Chaiyakunapruk, Nathorn
Publicado 2016

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses

por Leopold, Christine, Zhang, Fang, Mantel-Teeuwisse, Aukje K, Vogler, Sabine, Valkova, Silvia, Ross-Degnan, Dennis, Wagner, Anita K
Publicado 2014

The Brazilian private pharmaceutical market after the first ten years of the generics law

por Bertoldi, Andréa Dâmaso, Wagner, Anita K., Emmerick, Isabel Cristina Martins, Chaves, Luisa Arueira, Stephens, Peter, Ross-Degnan, Dennis
Publicado 2019

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020

por Zhang, Yichen, Naci, Huseyin, Wagner, Anita K., Xu, Ziyue, Yang, Yu, Zhu, Jun, Ji, Jiafu, Shi, Luwen, Guan, Xiaodong
Publicado 2022

Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe

por Davis, Courtney, Wagner, Anita K, Salcher-Konrad, Maximilian, Scowcroft, Henry, Mintzes, Barbara, Pokorny, Adrian M J, Lew, Jianhui, Naci, Huseyin
Publicado 2023